# clm_6E93433192ED

subject: Abbott Laboratories (/record/abbott-laboratories.md)  
predicate: total_equity  
value: 51,110,000,000 United States dollar  
valid_from: 2026-06-30  
valid_to: 2026-09-30  
published: 2026-07-28  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_1774BA675DC1  
last_updated: 2026-11-08  
cite: AsOf. "Abbott Laboratories total equity: 51,110,000,000 United States dollar", as of 2026-06-30 (until 2026-09-30). Claim clm_6E93433192ED, https://asof.is/claim/clm_6E93433192ED, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1800/000162828026050134/0001628280-26-050134-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q2 FY2026, filed 2026-07-28  

## Sources

- https://www.sec.gov/Archives/edgar/data/1800/000162828026050134/0001628280-26-050134-index.htm (primary, SEC EDGAR 10-Q Q2 FY2026, published 2026-07-28)

## Supersedes

- [Abbott Laboratories](/record/abbott-laboratories.md) | total_equity | 52,061,000,000 United States dollar | valid 2026-03-31 to 2026-06-30 | conf 0.95 | superseded | superseded_by [clm_6E93433192ED](/claim/clm_6E93433192ED.md) | [clm_3A1641DA4DD9](/claim/clm_3A1641DA4DD9.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.